The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites

被引:4
|
作者
Kim, Jun Jae [1 ]
Kim, Jeong Han [1 ]
Koo, Ja Kyung [1 ]
Choi, Yun Jung [1 ]
Ko, Soon Young [1 ]
Choe, Won Hyeok [1 ]
Kwon, So Young [1 ]
机构
[1] Konkuk Univ, Sch Med, Digest Dis Ctr, Dept Internal Med, Seoul, South Korea
关键词
End Stage Liver Disease; Liver Cirrhosis; Ascites; Mortality; Hyponatremia;
D O I
10.3350/cmh.2014.20.1.47
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The modification of the Model for End-Stage Liver Disease (MELD) scoring system (Refit MELD) and the modification of MELD-Na (Refit MELDNa), which optimized the MELD coefficients, were published in 2011. We aimed to validate the superiority of the Refit MELDNa over the Refit MELD for the prediction of 3-month mortality in Korean patients with cirrhosis and ascites. Methods: We reviewed the medical records of patients admitted with hepatic cirrhosis and ascites to the Konkuk University Hospital between January 2006 and December 2011. The Refit MELD and Refit MELDNa were compared using the predictive value of the 3-month mortality, as assessed by the Child-Pugh score. Results: In total, 530 patients were enrolled, 87 of whom died within 3 months. Alcohol was the most common etiology of their cirrhosis (n= 271, 51.1%), and the most common cause of death was variceal bleeding (n= 20, 23%). The areas under the receiver operating curve (AUROCs) for the Child-Pugh, Refit MELD, and Refit MELDNa scores were 0.754, 0.791, and 0.764 respectively; the corresponding values when the analysis was performed only in patients with persistent ascites (n= 115) were 0.725, 0.804, and 0.796, respectively. The significant difference found among the Child-Pugh, Refit MELD, and Refit MELDNa scores was between the Child-Pugh score and Refit MELD in patients with persistent ascites (P= 0.039). Conclusions: Refit MELD and Refit MELDNa exhibited good predictability for 3-month mortality in patients with cirrhosis and ascites. However, Refit MELDNa was not found to be a better predictor than Refit MELD, despite the known relationship between hyponatremia and mortality in cirrhotic patients with ascites.
引用
收藏
页码:47 / 55
页数:9
相关论文
共 50 条
  • [1] Predictive value of Refit Model for End-Stage Liver Disease, Refit Model for End-Stage Liver Disease-Na, and pre-existing scoring system for 3-month mortality in Korean patients with cirrhosis
    Koo, Ja Kyung
    Kim, Jeong Han
    Choi, Yun Jung
    Lee, Cho I.
    Yang, Jae Hoon
    Yoon, Hyeon Young
    Choi, Hye Jin
    Ko, Soon Young
    Choe, Won Hyeok
    Kwon, So Young
    Lee, Chang Hong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (07) : 1209 - 1216
  • [2] The Model for End-stage Liver Disease 3.0 is not superior to the Model for End-stage Liver Disease-Na in predicting survival: A retrospective cohort study
    Duan, Fangfang
    Liu, Chen
    Zhai, Hang
    Quan, Min
    Cheng, Jun
    Yang, Song
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (10)
  • [3] Model for End-Stage Liver Disease Sodium as a Predictor of Surgical Risk in Cirrhotic Patients With Ascites
    Maassel, Nathan L.
    Fleming, Matthew M.
    Luo, Jiajun
    Zhang, Yawei
    Pei, Kevin Y.
    JOURNAL OF SURGICAL RESEARCH, 2020, 250 : 45 - 52
  • [4] Model for end-stage liver disease-3.0 vs. model for end-stage liver disease-sodium: mortality prediction in Korea
    Kim, Jeong Han
    Cho, Yong Joon
    Choe, Won Hyeok
    Kwon, So Young
    Yoo, Byung-Chul
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, 39 (02) : 248 - 260
  • [5] Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis
    Lv, Xiao-Hui
    Liu, Hong-Bo
    Wang, Ying
    Wang, Bing-Yuan
    Song, Min
    Sun, Ming-Jun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (09) : 1547 - 1553
  • [6] Assessing liver dysfunction in cirrhosis: Role of the model for end-stage liver disease and its derived systems
    Lee, Yun-Hsuan
    Hsu, Chia-Yang
    Huo, Teh-Ia
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2013, 76 (08) : 419 - 424
  • [7] Model for End-Stage Liver Disease and liver cirrhosis-related complications
    Luis Calzadilla Bertot
    Eduardo Vilar Gomez
    Linnet Alonso Almeida
    Enrique Arus Soler
    Luis Blanco Perez
    Hepatology International, 2013, 7 : 347 - 355
  • [9] Relationship between model for end-stage liver disease score and left ventricular function in patients with end-stage liver disease
    Sun, Fu-Rong
    Wang, Ying
    Wang, Bing-Yuan
    Tong, Jing
    Zhang, Dai
    Chang, Bing
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2011, 10 (01) : 50 - 54
  • [10] Model for End-Stage Liver Disease and liver cirrhosis-related complications
    Calzadilla Bertot, Luis
    Vilar Gomez, Eduardo
    Alonso Almeida, Linnet
    Arus Soler, Enrique
    Blanco Perez, Luis
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 347 - 355